documents: FDA-2020-N-0002-0014
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2020-N-0002-0014 | FDA | FDA-2020-N-0002 | FOI Summary oA 200 673 approved April 22 2020:New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor | Supporting & Related Material | Background Material | 2021-03-08T05:00:00Z | 2021 | 3 | 2021-03-08T21:13:22Z | 0 | 0 | 0900006484a62c00 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref